Merkel cell carcinoma showing regression after biopsy: Evaluation of programmed cell death 1-positive cells

Noriki Fujimoto1, Gen Nakanishi, Miho Kabuto

  • 1Department of Dermatology, Shiga University of Medical Science, Shiga, Japan.

The Journal of Dermatology
|February 25, 2015
PubMed

Insights

Merkel cell carcinoma (MCC) regression after biopsy may involve reduced programmed cell death 1 (PD-1) positive cells. Lower PD-1 cell percentages in surrounding tissue suggest a role in suppressing tumor immunity for MCC.

Area of Science:

  • Immunology
  • Oncology
  • Dermatology

Background:

  • Merkel cell carcinoma (MCC) is an aggressive skin cancer.
  • Complete tumor regression after biopsy is observed but poorly understood.
  • T-cell mediated apoptosis is a proposed mechanism for MCC regression.

Observation:

  • Programmed cell death 1 (PD-1) is expressed on tumor-infiltrating T cells in MCC.
  • The role of PD-1-positive cells in MCC regression remains unevaluated.
  • A case of MCC with Merkel cell polyomavirus showed complete regression post-biopsy.

Findings:

  • The percentage of PD-1-positive cells among peritumoral mononuclear cells was significantly lower in the regressed MCC case compared to MCC without regression.
  • This suggests a potential inverse correlation between PD-1-positive cell infiltration and MCC regression.

Implications:

  • PD-1-positive cells may suppress anti-tumor immunity in MCC.
  • A reduction in PD-1-positive cells could be associated with spontaneous or biopsy-induced tumor regression in MCC.
  • Further research is warranted to explore the therapeutic potential of modulating PD-1 pathways in MCC.